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Abstract
Motivation: The human microbiome plays a key role in health and disease. Thanks to comparative
metatranscriptomics, the cellular functions that are deregulated by the microbiome in disease can
now be computationally explored. Unlike gene-centric approaches, pathway-based methods pro-
vide a systemic view of such functions; however, they typically consider each pathway in isolation
and in its entirety. They can therefore overlook the key differences that (i) span multiple pathways,
(ii) contain bidirectionally deregulated components, (iii) are confined to a pathway region. To cap-
ture these properties, computational methods that reach beyond the scope of predefined pathways
are needed.
Results: By integrating an existing module discovery algorithm into comparative metatranscrip-
tomic analysis, we developed metaModules, a novel computational framework for automated iden-
tification of the key functional differences between health- and disease-associated communities.
Using this framework, we recovered significantly deregulated subnetworks that were indeed recog-
nized to be involved in two well-studied, microbiome-mediated oral diseases, such as butanoate
production in periodontal disease and metabolism of sugar alcohols in dental caries. More import-
antly, our results indicate that our method can be used for hypothesis generation based on auto-
mated discovery of novel, disease-related functional subnetworks, which would otherwise require
extensive and laborious manual assessment.
Availability and implementation: metaModules is available at https://bitbucket.org/alimay/
metamodules/
Contact: a.may@vu.nl or s.abeln@vu.nl
Supplementary information: Supplementary data are available at Bioinformatics online.
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1 Introduction
The human microbiome is a functional community that plays an im-
portant role in health and disease (Huttenhower et al., 2012; Mitra
et al., 2013; Morgan et al., 2012). Disorders that have been previ-
ously linked to, for instance, the gut microbiome, include cardiovas-
cular disease (Wang et al., 2011) and type 2 diabetes (Qin et al.,
2012). Because distinct populations of microbes from different pa-
tients can harbor remarkably similar functional capabilities
(Turnbaugh et al., 2009), the pathogeneses of these diseases may not
necessarily be related to specific microbial population shifts from
the health-associated microbiome. Phenotypic differences are there-
fore better explained by changes in the regulation of cellular mech-
anisms, for instance in the form of under- or overexpression of
certain metabolic pathways or parts thereof. A prerequisite for this
is the ability to identify differentially expressed functional systems
using computational pipelines that can operate at the systems level.
The availability of such pipelines is likely to lead to increased discov-
ery of preventive and therapeutic targets in microbiome-related
diseases.
Metagenomics and metatranscriptomics are two powerful
approaches for studying, respectively, the functional capability and
activity of microorganisms in environmental and clinical samples.
The latter provides a more direct view into disease-associated factors
since microbial activity is often clinically more relevant than micro-
bial genetic potential. Supporting this are recent observations of
many metagenomically abundant gene families being consistently
downregulated at the transcriptional level, for instance, in the
human gut microbiome (Franzosa et al., 2014).
Comparative metatranscriptomics (meta-RNA-Seq) aims at iden-
tifying the functions that are significantly differentially expressed by
microbial communities under different conditions. Because the num-
ber of active microbial genes can reach up to several millions, the
functional profile of a sample is commonly constructed by mapping
mRNA reads first to genes, and then to higher-level functional units
such as KEGG Orthology groups (KOs, Kanehisa and Goto, 2000).
KOs are organism-independent identifiers that group together pro-
teins of similar biochemical functions. As with genes, they can be
used to perform differential expression analysis using packages such
as edgeR (Robinson et al., 2010) and DESeq2 (Love et al., 2014).
Since interpreting results at KO level is not straightforward, this is
typically followed by pathway or gene set enrichment analysis
(Subramanian et al., 2005) (as in Marchetti et al., 2012). Another
common approach is to use bioinformatics pipelines such as
MEGAN (Huson et al., 2007) or HUMAnN (Abubucker et al.,
2012) to map KOs to predefined functional modules and pathways,
such as those in the KEGG and MetaCyc (Caspi et al., 2014) data-
bases, and then to identify the deregulated functional units (as in
Franzosa et al., 2014).
Pathway-based approaches provide invaluable insights into dis-
ease biology; however, they have a number of shortcomings that are
critical for the identification of functional markers. First, they con-
sider each predefined pathway individually and therefore ignore the
interactions between pathways that may be crucial for discovering
causal biochemical mechanisms. Second, collapsing the expression
levels of KOs into pathways or modules can have two undesired out-
comes: non-differentially but highly expressed functions within a
pathway can obfuscate significant differences of other parts of the
same pathway. Moreover, pathways that contain up- and downre-
gulated genes may be determined as non-differentially expressed
overall. Finally, significantly deregulated pathway regions that are
not covered by predefined module delineations cannot be identified.
Methods that address the above limitations of pathway-based
methods have been previously reported. By combining protein-pro-
tein interaction networks with gene expression data, Ideker et al.
(2002) introduced the concept of identifying connected subsets of
regulatory genes that are responsible for changes in expression under
different conditions. This concept has since been extended to other
settings, including networks of enzymatic (Patil and Nielsen, 2005)
and regulatory elements (Oliveira et al., 2008). The central idea in
these methods can be summarized in three main steps: (i) construct-
ing a mathematical network (graph) that captures the core molecu-
lar interactions in biological pathways, (ii) assigning numerical
scores that reflect biological activity (or response) to the components
(edges/nodes) in the network and finally (iii) performing a search on
the network to identify the highly scoring subnetworks that delin-
eate the biological hotspots from the rest of the network [for a re-
view, see Mitra et al. (2013)].
The current work introduces metaModules; a novel approach
that focuses on comparative metatranscriptomic datasets for iden-
tifying metabolic subnetworks of significantly deregulated ortholo-
gous gene groups. An earlier work in this direction is MetaPath (Liu
and Pop, 2011), a method for finding differentially abundant en-
zymatic subnetworks in metagenomic datasets. The biological ques-
tions addressed by our method and MetaPath are fundamentally
different: whereas MetaPath is specifically designed to find subnet-
works of reactions that are either enriched or depleted as a whole in
a given experimental condition, metaModules focuses on finding
connected subsets of significantly deregulated ortholog gene groups.
Note that the subnetworks discovered by MetaPath do not have to
be composed of significantly differentially abundant or expressed
elements. Instead, the statistical significance of these subnetworks is
evaluated using a bootstrapping strategy. On the other hand, as it is
designed with a metatranscriptomic focus, our approach uses statis-
tics that are tailored to the properties of RNA-Seq data. Following
the work by Dittrich et al. (2008), our method specifically searches
for connected subnetworks that predominantly contain significantly
differentially expressed KOs, which can be either up- or downregu-
lated in different experimental conditions. Finally, the exact search
algorithm used by metaModules, Heinz (Dittrich et al., 2008), guar-
antees to find the optimal maximum-scoring subnetwork within the
input network.
We applied metaModules to previously published metatranscrip-
tomic datasets of two well-studied, oral microbiome-related dis-
eases: periodontal disease and dental caries. Periodontal (gum)
disease originates from an unbalanced host-microbiome interaction
that leads to an enhanced host inflammatory response. If left un-
treated, it causes the destruction of tooth-supporting structures and
may eventually result in tooth loss (Pihlstrom et al., 2005). Dental
caries (tooth decay) is one of the most common chronic diseases,
where the main cause is a net overproduction of acids during micro-
bial carbohydrate fermentation in the oral cavity, leading to the de-
mineralization of dental hard tissues (Selwitz et al., 2007). Using
metaModules, we recovered significantly deregulated connected
subnetworks of functions that are important in a number of mech-
anisms previously associated with these diseases, such as the produc-
tion of metabolites that inhibit human cell growth in periodontal
disease. Our results indicate that using high throughput data, our
methodology can be used to generate new hypotheses automatically
by uncovering novel disease-related metabolic mechanisms in micro-
bial communities. Although we demonstrated it on microbiome-
related disease datasets in this study, metaModules can be used for
datasets from any type of comparative metatranscriptomic studies.
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2 Methods
2.1 Metatranscriptomic data
We applied metaModules to metatranscriptomic datasets from re-
cently published studies of periodontal disease (Jorth et al., 2014)
and dental caries (Peterson et al., 2014). The periodontal disease
(PD) dataset consisted of patient-matched healthy (n¼3) and dis-
eased (n¼3) microbiome samples, each prepared by pooling subgin-
gival plaque from three healthy or diseased teeth. The dental caries
(DC) dataset comprised of supragingival plaque samples collected
from all dental surfaces of 36 individuals who had either a caries-
positive (n¼19) or a caries-negative (n¼17) oral health profile.
2.2 Preprocessing and mapping of reads
All methods within our pipeline mentioned below were used with
default parameters except where noted. Sickle v1.210 (available at
https://github.com/najoshi/sickle) was used to trim the 50-bp (PD)
and 100-bp (DC) single-end reads using an average quality score of
15 over a sliding window of 10% of the read length. Trimmed se-
quences shorter than 30-bp (PD) or 60-bp (DC) and those that con-
tained more than 10% ambiguous bases were discarded. Next,
human mRNA reads were filtered by Best Match Tagger v1.1.0
(available at ftp://ftp.ncbi.nih.gov/pub/agarwala/bmtagger/) using
the NCBI database of human mRNA transcripts predicted by NCBI
Gnomon. Subsequently, SortMeRNA v1.99-beta (Kopylova et al.,
2012) was used to filter the non-coding RNAs in the remaining
reads. As a second step for removing non-coding RNAs, the reads
were aligned using USEARCH (v7.0.1090, -usearch_local, Edgar,
2010) to a combination of sequences from the GtRNAdb tRNA
database (Chan and Lowe, 2009) and the SSURef_NR99 and
LSURef sequences (release 115) from the SILVA database (Quast
et al., 2013). An E-value cutoff of 1.0 and an identity threshold of
0.5 were used for the mapping, and mapped reads with bit-scores
>54 were removed as recommended by Leimena et al. (2013). The
remaining reads were aligned to a custom KEGG database
(Kanehisa and Goto, 2000) of 3 002 391 proteins from 2965 organ-
isms. Each protein in the database was a member of at least one of
the 8940 KEGG Orthology groups (KO). Each KO was further cate-
gorized under one or more of the 369 KEGG pathway maps. The
nucleotide-to-protein search, where the top 10 hits were kept for the
query reads, was performed using the ublast command in
USEARCH v7.0.1090 with an E-value threshold of 1000 for the PD
and of 10 for the DC dataset. For the PD dataset, a high E-value
threshold was required for mapping a sufficient number of short
reads (30- to 50-bp) in each sample; however, to minimize the ambi-
guity of matches in this case, a read coverage of 0.8 and an identity
level of 0.7 were used as additional alignment cutoffs.
2.3 Differential expression analysis
After the reads were mapped to KEGG proteins, gene counts were
estimated using a ‘best-hit’ approach by counting the number of
times a gene was mapped to a read as the best-matching target. In
the case of tied hits with the same E-value, the count for each top-
scoring gene was incremented. Note that, given the statistical frame-
work used for differential expression analysis is suitable, more
sophisticated methods such as HUMAnN (Abubucker et al., 2012),
which take into account the alignment quality and gene length dif-
ferences, can be used to estimate the counts.
Differential expression analysis at gene level was performed
using the R package DESeq2 v1.6.1 (Love et al., 2014). A multi-fac-
tor model was used for the paired samples in the PD dataset, while
for the DC dataset an unpaired analysis was performed by using the
default processing and analysis steps described in the DESeq2 pack-
age vignette.
KO counts were estimated by summing the counts of all genes
belonging to a given KO. Differential expression analysis at KO
level was performed as described for genes. The KOs with very low
mean of normalized counts were discarded by the independent filter-
ing option in DESeq2. While this filtering is optional in RNA-Seq
analyses that use the raw (and not the adjusted) P-values in their
pipeline, its use is recommended in metatranscriptomic datasets
where sparse counts may well lead to inaccurate results (Luo et al.,
2013).
2.4 Networks
We considered two KOs functionally interacting if there was a
KEGG relation defined between them in a given KEGG pathway
map (e.g. acting on the same compound in two successive reactions,
or sharing a direct signaling relationship). We combined these inter-
actions in a single network, removed self-loops and duplicated
edges, and obtained a global network of 6642 nodes (KOs) and
35 405 undirected edges (interactions) with a large connected com-
ponent (5547 nodes and 34 348 edges). The global networks for the
PD and DC datasets were obtained by taking the intersection of
KOs in the global KEGG network and those retained in the two
datasets, and then removing the non-interacting, isolated nodes in
the resulting networks, i.e. the nodes from which there is no path to
another node in the network.
2.5 Identification of maximum-scoring subnetworks
Given metatranscriptomic data from healthy and diseased individ-
uals and an interaction network of KOs, our goal is to identify func-
tional subnetworks of significantly deregulated KOs in microbial
communities. The subnetwork identification in metaModules is
based on the work by Dittrich et al. (2008). Here, each node in the
network is assigned a negative or a positive weight reflecting the
statistical significance of its differential expression (P-value), fol-
lowed by the application of a search algorithm (Heinz) that identi-
fies the optimal maximum-scoring connected subnetworks (MSS) in
the network.
As described by Pounds and Morris (2003), a P-value distribution
of differential expression data can be regarded as a mixture of two
distributions that model a signal and a noise component: P-values ob-
tained from the background noise alone will follow a uniform distri-
bution. On the other hand, the signal component, which arises from
true differences in expression, follows a Beta(a, 1) distribution. To de-
rive node weights from P-values, we first fitted a beta-uniform mix-
ture model to the distribution of P-values as described in Beisser et al.
(2010). Next, the mixture (k) and shape (a) parameters of this model,
the list of P-values and a false-discovery rate (FDR) were given as in-
put to the Heinz package to derive the node (KO) weights. The ad-
justed node score (weight) S of a P-value x is given by:
SðxÞ ¼ ða–1ÞðlogðxÞ–logðsðFDR; k; aÞÞÞ (1)
where s(FDR, k, a) is the significance threshold corresponding to the
specified FDR and the fitted values of k and a, as described in
Pounds and Morris (2003). The KOs with P-values lower than this
threshold are regarded as part of the signal and are assigned positive
weights, while KOs with higher P-values are assumed to constitute
the noise and are given negative weights. Note that the directionality
of deregulation does not play a role in the calculation of the weights.
In other words, the resulting MSSs do not have to be dominantly
up- or downregulated in a certain phenotype. However, if needed, a
metaModules identifies key functional subnetworks 3
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one-sided test can be used in the differential expression analysis step
to specifically search for subnetworks that are up- or downregulated
as a whole.
After the annotation of the KO network with weights, Heinz
was used to identify the MSS in each dataset. The networks were
visualized using the eXamine plugin (Dinkla et al., 2014) in
Cytoscape (Shannon et al., 2003).
2.6 Contribution of species to deregulated KOs
We determined the change in the contribution of individual organ-
isms to the identified subnetworks in health and disease
(Supplementary Fig. S1). Performing differential expression analysis
at both gene and KO level allowed us to obtain the mean expression
levels of genes and KOs in the healthy and diseased patient groups.
Note that the genes in our approach were annotated not only with
KOs but also with species using KEGG. Therefore, we were able to
determine the contribution of a species in terms of its gene expres-
sion to the KOs in the MSSs in different phenotypes. In our ap-
proach, each species s consists of a set of active genes
Gs¼ {gs,1,gs,2, . . . }. Similarly, each KO i in an MSS contains one or
more genes from a number of organisms Gi¼ {gi,1, gi,2, . . . }. The log
fold change in the expression of KO i for species s was then deter-
mined by:
FCs;i ¼ log2
X
g2Gi\GsgdX
g2Gi\Gsgh
0
@
1
A (2)
where gd and gh are the mean expression values of gene g across dis-
eased and healthy patient groups, respectively. Subsequently, for
each dataset, we identified the 10 species that showed the largest up-
and downregulation in disease across all KOs in the MSSs.
2.7 Comparison with other methods
We compared our method with MetaPath (Liu and Pop, 2011), the
only method currently available for identifying differentially abun-
dant MSSs in metagenomic datasets. We ran MetaPath with default
parameters to identify MSSs in the DC dataset (the PD dataset was
omitted since MetaPath is not applicable to paired samples). Among
the significant MSSs reported by the algorithm for the health- and
disease-associated phenotypes, we considered only the top-scoring
MSS for each phenotype. These enzymatic reaction subnetworks
were mapped back to a subnetwork of KOs, where the KO inter-
actions were determined using the global reaction network and the
reaction-to-KO mapping file provided with the MetaPath.
The topology of the global reaction network used by MetaPath
differs from the global KO network used in metaModules. To enable
a consistent comparison, we transformed MetaPath’s directed net-
work of reactions into an undirected network of KOs. We ran
metaModules using an FDR¼0.15 on this network to obtain an
MSS of similar size to the top-scoring MSSs obtained by MetaPath.
3 Results and discussion
3.1 Processing and mapping of reads
In total, we processed nearly two billion metatranscriptomic reads
from a periodontal disease (PD, Jorth et al., 2014) and a dental car-
ies (DC, Peterson et al., 2014) dataset. Both sets consisted of micro-
biome RNA samples taken from healthy and diseased conditions.
The reads were processed through three filtering steps: (i) quality
control, (ii) host mRNA filtering and (iii) removal of non-coding
RNAs. In the PD dataset, 53% of the reads were removed after the
quality control due to the large number of very short reads (15-bp)
that mainly comprised two of the three healthy samples (Table 1).
The percentage of non-coding RNAs in the remaining reads was re-
markably low (12%). On the contrary, the vast majority of reads
(93%) in the DC dataset passed the quality control; however, almost
85% of the reads were discarded after the removal of non-coding
RNAs, indicating substantial non-coding RNA contamination in the
samples. Both of the datasets contained similarly low levels of host
mRNA contamination (<2%). Both datasets had similar levels of
reads mapped to KEGG genes (<6%). The low percentage of
mapped reads is possibly due to the fact that our database contained
only the genes that were characterized in KEGG pathway maps.
Gene and KO counts were estimated as described in Section 2.3.
3.2 From the significance of deregulation to networks
Our goal was to identify significantly differentially expressed max-
imum-scoring connected subnetworks (MSS) in a global network of
interacting KOs. To find such subnetworks, each node (KO) in the
global network was assigned a weight that reflected the statistical
significance of its deregulation. These weights were calculated using
the P-value distribution of KO fold changes obtained by differential
expression analysis.
The subsequent filtering of KOs with low base mean expression
across all samples reduced their numbers in the PD and DC datasets
from 8882 and 8527 to 7105 and 5081, respectively. The numbers
of KOs up- and downregulated (P<1) in disease in the PD dataset
were, respectively, 3870 and 3235 (Supplementary Fig. S2A). In the
DC dataset, 2671 KOs were up- and 2410 were downregulated in
disease (Supplementary Fig. S2B).
To transform the P-values into weights, we fitted a beta-uniform
mixture (BUM) model to the distribution of P-values. The max-
imum-likelihood values of the mixture (k) and shape (a) parameters
of the BUM models were, respectively, 0.50 and 0.31 for the PD,
and 0.48 and 0.54 for the DC dataset.
For each dataset, the parameters of the BUM model, the list of P-
values and a false-discovery rate (FDR) were given as input to the
Heinz package (Dittrich et al., 2008), where KO weights were calcu-
lated following Equation (1). Heinz uses the FDR to calculate a sig-
nificance (P-value) threshold according to which KOs with lower
and higher P-values are assigned positive and negative weights, re-
spectively (Fig. 1, secondary axis). In the PD dataset, we used a strict
FDR¼0.0007 that corresponded to a very low significance thresh-
old P¼105 and constrained the number of positively scoring KOs,
which in return limited the size of the resulting MSS, to an interpret-
able scale (approximately 40 KOs). For allowing a similar number
of nodes to be positively scored in the more noisy DC dataset, we
used a larger FDR¼0.11 that corresponded to a significance thresh-
old P¼0.003 (Fig. 1B, red line). Both Figure 1A and B clearly show
the signal (the Beta distribution at low P-values) as well as the noise
component (the uniform distribution at higher P-values) in the data-
sets. For these FDR values, 134 nodes in the PD network (1.9%)
and 152 nodes in the DC network (3%) were assigned positive
weights, while the remaining nodes attained negative weights.
3.3 Significantly deregulated connected subnetworks
To obtain a global pathway map that covers the inter-pathway con-
nections, we integrated all KEGG pathways into a global KO net-
work of 6642 nodes (KOs) and 35 405 edges (KO interactions,
Section 2.4). By taking the overlap between the global network and
the KOs identified in the PD and DC datasets, we derived a global
disease-specific network for each dataset, each covering more than
4 A.May et al.
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53% of the KOs in the global network. Furthermore, each disease
network included a large connected component that contained at
least 77% of the nodes in the network as a whole.
Having the nodes of these global disease network annotated
with weights from the previous step, we used the Heinz algorithm
(Dittrich et al., 2008) and identified the connected MSS on each
network.
3.3.1 Periodontal disease
The maximum-scoring subnetwork identified in the periodontal dis-
ease dataset consisted predominantly of KOs that were upregulated
in disease (32 up- versus 7 downregulated in disease, Supplementary
Table S1), suggesting that key mechanisms involved in disease are
mostly due to overexpression of certain functions by the microbiome
rather than the lessening of those found in health. The KOs in the
subnetwork were members of 48 KEGG pathways in total (a single
KO can be a member of multiple pathways). Nonetheless, all KOs
upregulated in disease could be covered by the shown regions of six
KEGG pathways (Fig. 2A). Among these, parts of the lysine degrad-
ation and butanoate, pyruvate, and sulfur metabolisms included in
the subnetwork were almost entirely composed of KOs upregulated
in disease.
A vast part of the periodontal disease subnetwork that was upre-
gulated in disease covered the biochemical reactions that lead to the
production of butanoate, the conjugate base of butyric acid, by two
different mechanisms. The first mechanism appears to start with the
2-step breakdown of pyruvate to acetoacetyl-CoA in the pyruvate
metabolism, where acetoacetyl-CoA is fed into the butanoate metab-
olism (Supplementary Fig. S3). In the butanoate metabolism, four
KOs in the subnetwork covered the enzymatic steps necessary for
the conversion of acetoacetyl-CoA to butanoate (Supplementary Fig.
S4). The second mechanism was the lysine degradation pathway,
where other KOs in the subnetwork (all upregulated in disease) fully
covered the 6-step conversion of lysine to butanoate (Supplementary
Fig. S5). The involvement of butanoate in periodontal disease has
been known as an inhibiting agent for human cell growth (Chang
et al., 2013; Levine, 1985; Singer and Buckner, 1981). Additionally,
the subnetwork KOs in the sulfur metabolism covered two of the
three metabolic steps for the reduction of sulfate to sulfide. The role
of sulfate-reducing bacteria in periodontitis has been previously re-
ported as the production of cytotoxic levels of sulfide that lead to
cellular destruction (Langendijk et al., 1999, 2000). Other pathways
that were mainly upregulated in disease included arginine, proline,
glycine, serine and threonine metabolism.
Our results regarding disease-associated butanoate production
largely overlap with the findings reported in the original study of the
PD dataset (Jorth et al., 2014), where the authors describe the in-
volvement of lysine degradation in butanoate production. As an
addition to their findings, we report the apparent interplay between
the pyruvate and butanoate degradation pathways as a secondary
mechanism for butanoate production, as well as the involvement of
sulfide as a potential virulence factor in periodontal disease.
3.3.2 Dental caries
In contrast to periodontal disease, the maximum-scoring subnet-
work identified in the dental caries dataset was mostly downregu-
lated in disease (18 down- versus 13 upregulated KOs in disease,
Supplementary Table S2). The health-associated KOs were mainly
Table 1. Processing and mapping of reads for the two datasets
Dataset Samples (#) Raw reads After QC (%) After host mRNA
removal (%)
After t/rRNA
removal (%)
Mapped (%) Genes (#) KOs (#)
PD 6 773 306 101 46.6 44.8 33.1 4.5 2 195 939 8882
Disease 3 453 478 643 58.3 55.8 41.7 6.7 2 134 243 8872
Healthy 3 319 827 458 30.1 29.1 21.0 1.4 708 089 8290
DC 36 1 194 558 482 93.2 92.7 15.3 5.8 1 386 937 8527
Disease 19 643 025 297 93.8 93.5 14.4 5.6 1 073 778 8232
Healthy 17 551 533 185 92.4 91.8 16.3 6.1 1 079 242 8249
PD, periodontal disease; DC, dental caries.
The percentages are calculated with respect to the number of raw reads.
A B
Fig. 1. The P-value distribution of KO fold changes (primary axis) was used to calculate the node (KO) weights (the secondary axis) in the networks. (A) The peri-
odontal disease and (B) dental caries dataset. The red line shown for the caries dataset denotes the significance (P-value) threshold that separates KOs with posi-
tive and negative weights. Note that the black lines display the KO weights and not the BUM model fits to the distributions
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constituents of the pathways associated with amino acid biosynthe-
sis and pyrimidine, purine and pyruvate metabolism (Fig. 2B). In the
pyruvate metabolism, they covered the metabolic path for the break-
down of oxaloacetate to acetaldehyde. In contrast, oxaloacetate is
converted to another substance, phosphoenolpyruvate, by the only
KO in the pyruvate metabolism that was upregulated in disease
(K01596), suggesting a different role for the compound in disease.
The second pathway downregulated in disease was the biosynthesis
of amino acids. Together with the upregulation of these pathways in
health, we attribute the health-associated expression of KOs in the
purine and pyrimidine metabolism to bacterial growth and prolifer-
ation. This argument might be supported by the fact that, by using a
slightly higher false-discovery rate, the dental caries subnetwork
could have been extended to include six other KOs (all upregulated
in health) from the glycerophospholipid metabolism, the main prod-
ucts of which are the components of bacterial cell membranes
required for growth. Earlier studies show that the metabolic activity
of caries-promoting bacteria results in low pH conditions that dras-
tically affect the survival of other oral species (Bradshaw et al.,
1989; Harper and Loesche, 1984). On the other hand, in healthy
state, mutual interactions are necessary to obtain energy and main-
tain growth, for instance for the catabolism of salivary glycoproteins
(Dejong and Vanderhoeven, 1987).
The disease-associated parts of the caries subnetwork included 9
KOs from the pathways of phosphotransferase system and fructose
and mannose metabolism (Fig. 2B). Perhaps functionally the most
interesting of these KOs are the sugar phosphotransferases involved
in the beta-glucoside metabolism (K02755, K02756 and K02757).
The importance of beta-glucoside metabolism for cariogenic oral
bacteria has been put forward by studies showing the inhibitory ef-
fect of mutations in the beta-glucoside metabolism genes on biofilm
formation, a vital process for the colonization of these bacteria on
tooth surfaces (Kilic¸ et al., 2004). A secondary set of disease-associ-
ated KOs in the caries subnetwork that might be functionally inter-
esting are from the fructose and mannose metabolism. Four of these
KOs convert sorbitol to fructose 6-phosphate. Unlike many other
oral species, the well-known cariogenic bacteria Streptococcus
mutans can metabolize sorbitol and mannitol as a carbon source
(Ajdic et al., 2002) In contrast, the only KO downregulated in dis-
ease (K00844) in the same pathway converts fructose to fructose 6-
phosphate. Within fructose metabolism, this suggests that while in
health fructose is the main carbon source, in dental caries sorbitol
might be used as an additional source of carbon.
We note that the DC dataset in its original study (Peterson et al.,
2014) was not used to perform a differential expression analysis, but
rather an overall gene expression analysis of the healthy and dis-
eased samples as a whole. Therefore, to our knowledge, these are
the first results obtained from a metatranscriptomic dataset that aim
at elucidating the role of functional metabolic modules that are
involved in dental caries.
A B
C D
Fig. 2. The maximum-scoring subnetworks identified in (A) the periodontal disease and (B) dental caries datasets, where node colours denote the KO fold
changes. For (C) the periodontal disease and (D) dental caries datasets, species that showed the greatest up- and downregulation in the expression of these func-
tions in disease are shown. In all panels, red and blue, respectively, denote up- and downregulation in disease. Grey in (C) and (D) denotes the absence of KO ex-
pression in both health and disease. The coloured dots underneath the KOs in (C) and (D) correspond to the pathway colours as indicated in (A) and (B). The lists
of KO descriptions and full species names can be found in the Supplementary Tables S1–S3
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3.3.3 Significant subnetworks
To assess the likelihood of obtaining the MSSs identified in the PD
and DC datasets due to chance, we used a resampling procedure.
We randomly shuffled the KO weights in the global disease net-
works, calculated the MSSs in the networks with shuffled weights,
and determined the cumulative weight of the identified subnetworks
(n¼500). In the PD dataset, none of the 500 shuffled networks re-
sulted in an MSS that outscored the periodontal disease subnetwork.
For the DC dataset, only 36 out of 500 MSSs attained cumulative
scores that were higher than that of the caries subnetwork. We attri-
bute these 36 random networks to the lower signal content and
the higher FDR used in the dental caries dataset. The compari-
son between the cumulative weights of original subnetworks
and those that resulted from resampling strongly indicates that
the results reported above are not originating from random effects
(Supplementary Fig. S6).
3.4 Contribution of different species to subnetworks
Previous studies of microbiome-related diseases have demonstrated
that the metabolic functions associated with disease or health may
be performed by particular taxonomic groups within a microbial
community (Belda-Ferre et al., 2012; Man et al., 2011). To deter-
mine whether this applies to the functional disease subnetworks
we identified in this study, we determined the lists of 10 species
that showed the greatest overall increase or decline in disease in the
expressions of functions that were found in the subnetworks
(Section 2.6).
3.4.1 Periodontal disease
The KOs in the butanoate metabolism were upregulated by almost
all of the top 10 species that showed the largest increase in the ex-
pression of periodontal disease subnetwork KOs in disease, includ-
ing the well-known periodontal pathogens Porphyromonas
gingivalis and Fusobacterium nucleatum (Fig. 2C). Previously, only
the F. nucleatum species was proposed to be responsible for buta-
noate production (Jorth et al., 2014). Our analysis suggests other-
wise; a wider range of organisms seems responsible for the
production of butanoate. Note that our reference metagenome data-
base included genes from all species in KEGG, while Jorth et al.
(2014) used genomes of 60 oral species to construct their reference
database, which may explain why we were able to find a wider
range of species.
Although expressing all other KOs in the butanoate metabolism,
P. gingivalis and Odoribacter splanchnicus surprisingly did not ex-
press one of the key KOs in the same pathway (K00626, EC 2.3.1.9
in Supplementary Fig. S4). This suggests that in these bacteria, this
function is covered by enzymes from other pathways, or that its
product (acetoacetyl-CoA) is acquired from the environment.
3.4.2 Dental caries
The 10 species that showed the greatest upregulation of the KOs in
the dental caries subnetwork in disease included Streptococcus
mutans and Lactobacillus casei, which frequently are associated
with dental caries (Fig. 2D). Interestingly, in addition to the well-
known cariogenic species, we observe, as in the periodontal disease
dataset, a wider range of species with a similar pathogenic expres-
sion profile in the maximum-scoring subnetwork.
A contradictory finding in this section is that Streptococcus,
Clostridium and Lactobacillus species appear to show an increased
expression of adenosine deaminase (K01488) in purine metabolism
in the disease state. One of the products of this enzyme is ammonia,
the production of which increases the pH in the oral cavity and
therefore is generally described as an inhibitory factor on caries de-
velopment (Burne et al., 2012; Koopman et al., 2015). This result is
even more intriguing, considering that the species showing the great-
est overall upregulation of the KOs in the caries module in health
did not show increase in the expression of adenosine deaminase.
3.5 Comparsion with other methods
As there is currently no other method for identifying subnetworks of
significantly deregulated KOs in metatranscriptomics datasets, we
compared our approach with MetaPath, a method that is developed
for solving a similar but fundamentally different biological problem.
Unlike metaModules, MetaPath aims to find subnetworks of enzym-
atic reactions that are enriched or depleted as a whole in a given ex-
perimental condition.
Since the global metabolic networks natively used by the two
methods are different, for consistency, we applied both methods on
the MetaPath network (see Section 2.7 for details).
The comparison of their results immediately makes it clear that
the two methods address distinct biological questions: whereas
MetaPath finds subnetworks of fully up- or downregulated KOs,
metaModules finds a subnetwork in which the vast majority of KOs
is significantly deregulated (Supplementary Figs S7 and S9).
The overlap of 7 KOs between the subnetworks calculated by
metaModules and MetaPath are parts of the two disease-associated
pathways described in Section 3.3: fructose and mannose metabol-
ism and phosphotransferase system (Supplementary Figs S7 and S8).
This finding is in line with the above conclusions; both of these path-
ways were mostly significantly deregulated in a certain phenotype
(caries-positive) and therefore were parts of the solution spaces of
both methods.
In conclusion, these results suggest that the two methods are
complementary as they address different questions.
3.6 Metabolic pathways in microbial communities
Since microbial communities can communicate and interact by
exchanging metabolites (Rath and Dorrestein, 2012), metabolic
pathways and in particular KOs are well-suited to study the gene ex-
pression levels in full microbial communities and changes thereof in
disease-associated communities. The suitability of our approach
within this framework is highlighted by the recovery of essential up-
and downregulated subnetworks by the analysis of high throughput
metatranscriptomic datasets. Within our datasets, we do
indeed seem to find hints of species relying on other species within
the community, e.g. as a source for metabolites. This means that
high throughput sequencing experiments will in fact be one of the
most common ways to study such species, as culturing such organ-
isms in the laboratory will be understandably difficult (Ling et al.,
2015). Therefore, the computational methodology developed here
to study these mechanisms in their natural communities will be im-
portant to understand the full mechanisms of microbiome-related
diseases.
4 Conclusion
We developed a new methodology for comparative metatranscrip-
tomics that facilitates the automated identification of metabolic hot-
spots that are significantly deregulated in disease, and recovered
disease-associated functions in two oral microbiome-mediated dis-
orders. The diseases examined in this work, periodontal disease and
dental caries, have been extensively investigated using a wide range
metaModules identifies key functional subnetworks 7
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of experimental methods in previous studies. Being able to automat-
ically recover large parts of the known disease biology using single
high throughput transcriptomic datasets from full microbial com-
munities is an important step forward for the discovery of currently
unknown factors in microbiome-mediated diseases.
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